Related by context. All words. (Click for frequent words.) 78 Relapsing Multiple Sclerosis 77 Newly Diagnosed Multiple Myeloma 77 Meets Primary Endpoint 77 Patients Receiving 77 Oral Fingolimod 76 Metastatic Prostate Cancer 76 Advanced Melanoma 76 Improves Outcomes 76 Relapsed Multiple Myeloma 76 Appears Safe 76 Adjuvant Treatment 76 Antitumor Activity 76 Renal Cell Carcinoma 76 Monotherapy 75 Relapsed Refractory 75 Phase 2b Clinical Trial 75 Metastatic Renal Cell Carcinoma 75 Elderly Patients 75 Previously Treated 75 Cutaneous T 75 Is Well Tolerated 75 Improves Survival 75 Patients Treated With 75 Long Term Efficacy 75 Patients Treated 75 Hormone Refractory Prostate Cancer 74 Ischemic Stroke 74 Prolongs Survival 74 Phase 2b Trial 74 Complicated Skin 74 Pooled Analysis 74 Chronic Hepatitis B 74 Overactive Bladder 74 Rheumatoid Arthritis Patients 74 Fracture Risk 74 Soft Tissue Sarcoma 74 Metastatic Colorectal Cancer 74 Resistant Hypertension 74 Previously Untreated 74 Disease Progression 74 Castration Resistant Prostate Cancer 74 Clinical Trial Results 74 Chronic Hepatitis C 74 Knee Osteoarthritis 74 Follicular Lymphoma 74 Improved Survival 74 Renal Impairment 74 Treated Patients 74 Survival Benefit 73 Demonstrate Significant 73 Demonstrated Significant 73 Malignant Glioma 73 Localized Prostate Cancer 73 Study Evaluating 73 Severe Sepsis 73 Statistically Significant 73 Myelodysplastic Syndromes 73 Novel Oral 73 Inhaled Corticosteroids 73 Plus Ribavirin 73 Controlled Trial 73 Phase III Trial 73 Refractory Hodgkin Lymphoma 73 Anti Tumor Activity 73 Phase 2a Clinical Trial 73 Heart Failure Patients 73 Mouse Model 73 Chronic Myeloid Leukemia 73 Combination Treatment 73 Shows Efficacy 73 Chronic Sinusitis 73 Prospective Randomized 73 Phase IIb Trial 73 Hypertensive Patients 73 Prophylactic Treatment 73 Improve Survival 73 Treatment Experienced 73 Advanced Prostate Cancer 72 II Clinical Trial 72 Subgroup Analysis 72 Phase III Clinical Trial 72 Adjuvant Chemotherapy 72 HER2 Positive Breast Cancer 72 Postmenopausal Osteoporosis 72 Cognitive Impairment 72 Cardiovascular Outcomes 72 Orally Active 72 Cardiovascular Events 72 Atypical Hemolytic Uremic Syndrome 72 Pivotal Phase III 72 Unresectable 72 Slow Progression 72 Breast Cancer Recurrence 72 Demonstrates Positive 72 Treatment Naive Patients 72 ST Elevation Myocardial 72 Lupus Nephritis 72 Diabetic Nephropathy 72 Nebulized 72 Treating Chronic 72 Unfractionated Heparin 72 Fungal Infections 72 Postmenopausal Women 72 Phase IIa Clinical Trial 72 Lowers Risk 72 Juvenile Idiopathic Arthritis 72 Single Dose 72 Adjuvant Therapy 72 Hypercholesterolemia 72 Malignant Melanoma 72 Well Tolerated 72 Suicidality 72 Interferon beta 1a 72 Benign Prostatic Hyperplasia 71 Thromboembolism 71 Hormone Receptor Positive 71 Adjunctive Therapy 71 Bipolar Depression 71 Randomized Study 71 Carotid Stenting 71 Significantly Reduced 71 Infected Patients 71 Demonstrates Efficacy 71 Cholesterol Lowering Drug 71 Demonstrates Significant 71 Bone Metastases 71 Pediatric Patients 71 Generalized Anxiety Disorder 71 Patients Undergoing 71 Levels Linked 71 Clinically Isolated Syndrome 71 Advanced Colorectal Cancer 71 Fewer Side Effects 71 Safinamide 71 Combo Therapy 71 Investigational Treatment 71 Pharmacokinetics PK 71 Liver Failure 71 Treatment Shows Promise 71 Diffuse Large B 71 Cholesterol Levels 71 Natalizumab 71 Significantly Improved 71 Prostate Cancer Patients 71 Nilotinib 71 Plaque Psoriasis 71 Combination REOLYSIN R 71 Advanced Solid Tumors 71 Chronic Constipation 71 Allergic Rhinitis 71 Non Responders 71 Treatment Resistant 71 Phase 2b Study 71 Partial Onset Seizures 71 Myelodysplastic Syndrome MDS 71 Sustained Reduction 71 Sustained Efficacy 71 ACE Inhibitors 71 Advanced Renal Cell 71 Drug Candidate 71 Pivotal Phase 71 Randomized Double Blind 71 Seasonal Allergic Rhinitis 71 Hepatitis C Genotype 71 Cell Lymphoma 71 Secondary Hyperparathyroidism 71 Ischemic 71 Phase IIb Clinical Trial 71 induce orthostatic hypotension 71 Placebo Controlled Trial 71 Adjunctive 70 Statin Therapy 70 Shows Promise Against 70 Pivotal Study 70 Orthostatic Hypotension 70 Invasive Breast Cancer 70 Endometrial Cancer 70 Lung Cancer Trial 70 Endothelial Function 70 Bone Mineral Density 70 Antipsychotic 70 Peginterferon 70 Chronic Heart Failure 70 dual endothelin receptor antagonist 70 Fludarabine 70 Septic Shock 70 Patients Suffering 70 Myelofibrosis 70 Gout Drug 70 Desvenlafaxine Succinate 70 Controlled Study 70 Study Showed 70 Adalimumab 70 Comorbidities 70 Tiotropium 70 Epratuzumab 70 Clinical Trial Evaluating 70 Tolerability 70 Interferon Beta 70 Chronic Renal Failure 70 Viral Load 70 Pulmonary Arterial Hypertension 70 Showed Significant 70 Renal Cancer 70 Relapsed Refractory Multiple Myeloma 70 SPRYCEL ® 70 Investigational Agent 70 Chronic Lymphocytic Leukemia 70 relapsed MM 70 Unstable Angina 70 Autologous Stem Cell Transplantation 70 Venous Thromboembolism 70 Chemoradiation 70 Shows Promising 70 Treatment Reduces 70 Data Suggest 70 Drug Shows Promise 70 Heterozygous Familial Hypercholesterolemia 70 Viral Suppression 70 Demonstrates Potent 70 Meta Analysis 70 Acute Ischemic Stroke 70 PEGylated interferon beta 1a 70 Trial Evaluating 70 moderate renal impairment 70 Anthracycline 70 Fixed Dose 70 Irritable Bowel 70 Randomized Phase 70 Naive Patients 70 Breast Cancers 70 Nucleoside 70 Cardiogenic Shock 70 Cardiac Resynchronization 70 Critically Ill Patients 70 Diabetic Patients 70 recurrent glioblastoma multiforme 70 Osteoporosis Drugs 70 Investigational Compound 70 Serious Infections 70 Enlarged Prostate 70 Relapsed 70 Proves Effective 69 Bare Metal Stents 69 See CLINICAL PHARMACOLOGY 69 Radical Prostatectomy 69 Beta Blocker 69 Acute Heart Failure 69 Hsp# Inhibitor 69 Lung Cancer Patients 69 Inflammatory Markers 69 metastatic malignant 69 Neuroprotective Effects 69 Treatment Naive 69 Invasive Fungal Infections 69 Acute Pancreatitis 69 Phase III Trials 69 Neovascular Age Related Macular 69 Cardiotoxicity 69 Allogeneic 69 Anti Tumor 69 Posaconazole 69 Fulvestrant 69 Double Blind Placebo 69 Gene Linked 69 Tocilizumab 69 Ranolazine 69 Glatiramer Acetate 69 Node Positive 69 achieved CCyR 69 Newly Diagnosed 69 Depressive Symptoms 69 Decitabine 69 Disease Modifying 69 Slows Progression 69 Efficacy Trial 69 unfractionated heparin UFH 69 Lamotrigine 69 Metastatic Melanoma 69 Exacerbation 69 Treatment Naive HIV 69 STRIDE PD 69 Artery Disease 69 Bosutinib 69 Multiple Myeloma Patients 69 Myeloma Patients 69 Gene Variant 69 Severe Asthma 69 Significantly Reduces 69 Proteinuria 69 Fondaparinux 69 Demonstrates Sustained 69 Pharmacokinetic Study 69 Completes Patient Enrollment 69 Versus Placebo 69 Diabetic Neuropathic Pain 69 Antitumor 69 Left Ventricular 69 Randomized Phase II 69 Clinical Efficacy 69 Postherpetic Neuralgia 69 Peginterferon Alfa 2b 69 Hypotension 69 Antipsychotic Medications 69 Treating Heart Failure 69 Therapy Shows Promise 69 Acute Myocardial Infarction 69 Panic Disorder 69 Leukemias 69 Genes Predict 69 Double Blind Randomized 69 Study Demonstrates 69 Lupus Drug 69 Tigecycline 69 Gastrointestinal Stromal Tumors 69 Hemoglobin Levels 69 Nymox NX 69 Progressive Multifocal Leukoencephalopathy 69 Advanced Ovarian Cancer 69 Dose Escalation 69 Paroxysmal Nocturnal Hemoglobinuria PNH 69 Valvular Heart Disease 69 Patency 69 Remission Maintenance 69 Sustained Virologic Response 69 Multicenter Trial 69 Placebo Controlled Study 69 Chronic Bronchitis 69 Peginterferon Alfa 2a 69 ACTEMRA TM 69 Thrombotic 69 Phase 2a Trial 69 Clinical Outcome 69 Patient Enrollment 69 Stent Restenosis 69 Metastatic Pancreatic Cancer 69 Effectively Treats 68 First Patient Dosed 68 Chronic Liver Disease 68 Platelet Inhibition 68 Completes Enrollment 68 Brain Metastases 68 Sirolimus Eluting Stent 68 Virus Infection 68 Protease Inhibitor 68 Reduces Mortality 68 Randomized Trials 68 Treatment Naïve 68 Therapy Improves 68 relapsing remitting MS RRMS 68 Hepatitis C Patients 68 Hepatic Encephalopathy 68 Nonalcoholic Fatty Liver Disease 68 Neoadjuvant Chemotherapy 68 Cognitive Decline 68 Phase Ib Clinical Trial 68 Efficacious 68 Phase III Pivotal Trial 68 Combination Therapy 68 Major Depressive Disorder 68 Kidney Function 68 Drug Resistant 68 Bipolar Mania 68 PEGINTRON TM 68 Unstable Angina Non 68 Epoetin Alfa 68 Epilepsy Drug 68 Iron Deficiency 68 Dasatinib 68 Complete Remission 68 Bronchiectasis 68 Systemic Sclerosis 68 Tyrosine Kinase Inhibitor 68 Sleep Disturbances 68 Pivotal Clinical Trial 68 PEG IFN 68 Preterm Delivery 68 Generalized Anxiety Disorder GAD 68 Tipranavir 68 Non Alcoholic Steatohepatitis 68 Acute Exacerbations 68 Premenopausal Women 68 Clostridium difficile Infection 68 Randomized Controlled Trials 68 Chronic HCV 68 Increases Risk 68 Enoxaparin 68 Novel Inhibitor 68 Renal Anemia 68 Gastric Cancer 68 Azacitidine 68 Poorly Controlled 68 Blood Pressure Drug 68 alfa 2a 68 Blood Clot Risk 68 Paroxysmal Nocturnal Hemoglobinuria 68 Oral Anticoagulant 68 Risedronate 68 Cyclophosphamide 68 Hip Fractures 68 First Patient Enrolled 68 Premature Infants 68 Receives Orphan Drug Designation 68 JAK Inhibitor 68 moderate hepatic impairment 68 Colorectal Cancer Patients 68 Androgen Deprivation Therapy 68 Oral Formulation 68 Valvular 68 Significantly Improves 68 Potentially Fatal 68 HER2 Positive 68 Pivotal Trial 68 Adefovir 68 Beta Blockers 68 Prostatic 68 Bevacizumab 68 Insulin Glargine 68 Chronic Myelogenous Leukemia 68 Kidney Transplant Patients 68 Intracerebral Hemorrhage 68 Brain Atrophy 68 Long Term Outcomes 68 Improve Outcomes 68 Refractory Angina 68 Predict Risk 68 bone marrow reticulin deposition 68 Betaferon R 68 Newly Diagnosed Patients 68 Atopic Dermatitis 68 complement inhibitor eculizumab 68 Aggressive Prostate Cancer 68 Radiofrequency Ablation 68 Renal Function 68 Aflibercept 68 Anticoagulant 68 Pemetrexed 68 Antidepressant Use 68 Non Alcoholic Fatty 68 TO AVOID PREGNANCY WHILE 68 Investigational Drug 68 Rheumatoid Arthritis Drug 68 Acute Coronary Syndromes 68 Thromboembolic 68 HeFH 68 Hepatotoxicity 68 Oral Cladribine 68 8mg/kg 68 Hemolysis 68 Vildagliptin 68 icatibant 68 Degarelix 68 Cognitive Function 68 Antiviral Activity 68 BARACLUDE ® 68 Squamous 68 Immunosuppression 68 Rheumatoid Arthritis RA 68 Hepatocellular Carcinoma 68 hyperphenylalaninemia HPA due 68 relapsing multiple sclerosis 68 Etanercept 68 Carboplatin Paclitaxel 68 Lung Cancer Survival 68 Antiangiogenic 68 Magnetic Stimulation 68 Teva Provides Update 68 Anti TNF 68 ST Segment Elevation 68 Long Term Survival 68 STELARA TM 67 Hyperlipidemia 67 Tumor Growth 67 Obesity Linked 67 Hospital Acquired Pneumonia 67 mitoxantrone plus 67 Post Operative 67 Myelodysplastic Syndrome 67 Restenosis 67 Venous Thrombosis 67 Preclinical Data 67 AA Amyloidosis 67 Relapsed Refractory Aggressive 67 Drug Prevents 67 Attenuates 67 Hemodialysis Patients 67 Fibromyalgia Pain 67 Mycophenolate Mofetil 67 Insulin Sensitivity 67 Skeletal Muscle 67 Recurrent Breast Cancer 67 Migraine Headaches 67 Antidepressants Linked 67 Adenomas 67 Cardiovascular Disease Risk 67 Pegylated Liposomal Doxorubicin 67 External Beam 67 Patients Enrolled 67 Lenalidomide 67 IN PATIENTS WITH 67 Renal Cell Cancer 67 Psychiatric Disorders 67 Ziprasidone 67 Chronic Prostatitis 67 FDA Approvals 67 Brentuximab Vedotin SGN 67 Reduced Risk 67 Recurrent Glioblastoma 67 Proven Effective 67 Nonspecific 67 B Cell Lymphoma 67 Low Density Lipoprotein Cholesterol 67 Medoxomil 67 Low Dose 67 Receives Positive Opinion 67 Romiplostim 67 Telithromycin 67 Immunomodulatory 67 Eculizumab 67 Stent Implantation 67 Vertebral Compression Fractures 67 Achieves Primary Endpoint 67 Postmenopausal 67 Anticancer Activity 67 Gastric Ulcers 67 Respiratory Distress 67 Primary Hypercholesterolemia 67 Renal Artery 67 Treatment Naïve Patients 67 beta 1a 67 Initiate Phase 67 Left Ventricular Hypertrophy 67 Cervical Dysplasia 67 Randomized Double blind 67 Initiates Clinical Trial 67 Significant Reduction 67 Often Misdiagnosed 67 Pharmacodynamics 67 Mg Usa 67 Acute Decompensated Heart Failure 67 Therapy Reduces 67 HIV HCV coinfected 67 Capecitabine 67 Nicotine Vaccine 67 severe oral mucositis 67 Randomized Clinical Trials 67 Physical Function 67 mild renal insufficiency 67 Zoledronic Acid 67 Chemotherapy Induced 67 JAK2 Inhibitor 67 Obese Patients 67 Stomach Cancer 67 Amgen Neulasta R 67 Protein Linked 67 Granted Orphan Drug 67 Prospective Randomized Trial 67 Expanded Indication 67 Novel Compound 67 Sirolimus Eluting 67 Vaccine Candidate 67 Urinary Tract Infections 67 Kidney Transplant Recipients 67 CTAP# Capsules 67 Bosentan 67 Inhaled Nitric Oxide 67 Catheter Ablation 67 CYT# potent vascular disrupting 67 Neoadjuvant 67 Cancer Recurrence 67 B Cell Malignancies 67 Stable Angina 67 Toxicities 67 Danazol 67 Allergic Asthma 67 ritonavir boosted 67 Prostate Cancer Recurrence 67 Bone Fracture 67 Patient Outcomes 67 Progenitor Cells 67 ara C 67 Study Shows Promise 67 selective modulator 67 Ibritumomab Tiuxetan 67 Blood Clots 67 CYP#A# substrate 67 Rheumatoid 67 Bone Fractures 67 non splenectomized 67 Recurrent Stroke 67 Successfully Treated 67 Transdermal Patch 67 Antiplatelet Therapy 67 Acute Renal Failure 67 Contrast Agents 67 Lung Cancer Risk 67 Increased Mortality 67 Rotavirus Vaccine 67 Glucose Control 67 Mg Uk 67 Sipuleucel T 67 atypical Hemolytic Uremic Syndrome 67 Hyperuricemia 67 Minimally Invasive Treatment 67 Osteoarthritis Patients 67 Epidermal Growth Factor Receptor 67 Abciximab 67 HCV Protease Inhibitor 67 Idiopathic Pulmonary Fibrosis 67 Renal Insufficiency 67 Critical Limb Ischemia 67 Pegylated Interferon 67 Randomized Clinical Trial 67 Golimumab 67 Oral Mucositis 67 FASLODEX 67 Intravitreal 67 Emerging Therapies 67 Topline Results 67 desvenlafaxine succinate 67 Randomized Double Blind Placebo 67 Stent Thrombosis 67 T2DM 67 Induction Therapy 67 FDA APPROVES 67 Polyneuropathy 67 Melphalan 67 Diabetic Foot Ulcer 67 ORENCIA ® 67 headache abdominal pain 67 Diabetic Neuropathy 67 ankylosing spondylitis AS 67 Antiplatelet 67 NDA Submission 67 Capsules CII 67 Colorectal Adenomas 67 Hepatic Impairment 67 Prolongs Life 66 Presents Positive 66 myelodysplastic myeloproliferative diseases 66 Advanced Pancreatic Cancer 66 adalimumab Humira 66 Acute Coronary 66 FDA Approves Drug 66 Bloodstream Infections 66 Phase III Clinical Trials 66 Predict Response 66 Chronic Cough 66 Dose Ranging Study 66 Genes Linked 66 Squamous Cell Carcinoma 66 Bare Metal Stent 66 Infarct 66 Diabetic Foot Ulcers 66 Vertebral Fractures 66 Gene Mutation 66 Tumor Response 66 Statin Drugs 66 Myocardial Ischemia 66 Limb Ischemia 66 Atomoxetine 66 bronchial hyperresponsiveness 66 Cilostazol 66 Cyclooxygenase 2 66 Kinoid 66 Drug Combo 66 Bivalirudin 66 Sandostatin R 66 Watchful Waiting 66 Reduces Pain 66 Pulmonary Artery 66 FDA Okays 66 Intracranial Aneurysms 66 INVEGA ® 66 Tacrolimus 66 Glioblastoma Multiforme 66 Community Acquired Pneumonia 66 Diabetic Macular Edema 66 Lymphocytic 66 Randomized Placebo Controlled Trial 66 Synta Announces 66 Beneficial Effects 66 Skin Lesions 66 Ischaemic 66 Immunomedics Announces 66 smoldering multiple myeloma 66 Abdominal Pain 66 Submits NDA 66 Aliskiren 66 Chronic Insomnia 66 Angioedema 66 Protease Inhibitors 66 SNT-MC#/idebenone 66 Lipid Levels 66 ® lenalidomide 66 Short Stature 66 intravascular hemolysis 66 Paclitaxel Carboplatin 66 Pegloticase 66 neutropenia dehydration dyspnea 66 Coronary Arteries 66 Multicenter Study 66 Hematologic 66 Platinol ® 66 Glycemic Control 66 Radiofrequency Ablation RFA 66 Vaginal Gel 66 Nesiritide 66 Diagnostic Criteria 66 Blood Cholesterol 66 Critical Limb Ischemia CLI 66 Clot Busting 66 Initiates Enrollment 66 Initiate Phase III 66 Atypical Antipsychotic 66 Shows Statistically Significant 66 Kidney Tumors 66 Liver Metastases 66 AVONEX ® 66 Predictive Value 66 arthritis PsA 66 Free Survival PFS 66 SGPT 66 Symptom Improvement 66 Bone Marrow Cells 66 Sapacitabine 66 Kidney Failure 66 C1 Inhibitor 66 Randomised Trial 66 Phospholipase A2 66 Preclinical Models 66 Effective Treatments 66 Ribavirin causes 66 Pneumococcal Vaccine 66 Parathyroid Hormone 66 Efficacy Results 66 Diuretic 66 Coronary Angiography 66 Chemotherapy induced 66 Functional Outcomes 66 Solid Tumors 66 Leukemia AML 66 Mayo Clinic Study Finds 66 Peripheral Arterial 66 Preclinical Study 66 Infarction 66 humanized interleukin 6 66 Prostate Tumors 66 Metabolic Efficiency 66 Survival Rates 66 hypercholesterolaemia 66 Stage IIB 66 Osteoporosis Drug 66 HBeAg + 66 Confirmatory Phase 66 Asymptomatic 66 Acute Migraine 66 stage IIIB 66 CIMZIA R 66 Prostate Biopsy 66 Systemic Lupus Erythematosus SLE 66 Menopausal Women 66 Virus Linked 66 Rilonacept 66 diarrhea predominant irritable 66 TNF Tumor Necrosis Factor 66 Immune Responses 66 C Reactive Protein 66 Experimental Vaccine 66 Non Inferiority 66 Treat Anemia 66 Dose Finding 66 psoriatic arthritis PsA 66 Retreatment 66 Cholesterol Drugs 66 Valsartan 66 receiving VELCADE 66 Liver Injury 66 Neuroendocrine Tumors 66 Lacosamide 66 Testosterone Levels 66 Insulin Resistance 66 Dual Antiplatelet Therapy 66 evaluating tivozanib 66 See CONTRAINDICATIONS 66 Boosts Survival 66 Schizoaffective Disorder 66 Autoimmune Diseases 66 Antifungals 66 Randomized Controlled 66 Drug Fails 66 ATACAND 66 rilonacept 66 Ovarian Cancer Patients 66 idiopathic Parkinson disease 66 Laryngeal Cancer 66 Late Breaker 66 Chronic Pelvic Pain 66 Gene Therapy Trial 66 Ventricular Arrhythmias 66 Gene Variation 66 Reduces Risk 66 active ankylosing spondylitis 66 Dyslipidemia 66 Immunosuppressant 66 Trastuzumab 66 Prostate Cancer Risk 66 Secondary Endpoints 66 Oral Calcitonin 66 haematologic 66 Stem Cell Transplants 66 Physician Insights 65 Monoclonal Antibody 65 bacterial prostatitis 65 IND Application 65 Mantle Cell Lymphoma 65 Vicriviroc 65 Thiazolidinediones 65 Randomised 65 Lipid Lowering 65 Randomized Controlled Trial 65 chronic immune thrombocytopenic 65 Spinal Fusion 65 Humanized Anti 65 Gene Mutation Linked 65 Severe Psoriasis 65 secondary hyperparathyroidism 65 Novel Therapeutic 65 Known hypersensitivity 65 Increased Risk 65 Schizophrenia Treatment 65 Immune Mediated 65 Multicenter Phase 65 Benign Prostatic Hyperplasia BPH 65 Catheter Associated 65 Fluorouracil 65 Vaccine Adjuvant 65 Colorectal Cancer Risk 65 relapsed Acute Myeloid 65 Antihypertensive 65 NICE Recommends 65 Systolic Blood Pressure 65 Dupuytren Contracture 65 Arterial Disease 65 Paroxysmal Atrial Fibrillation 65 Antibiotic Treatment 65 Prognostic Value 65 TNF Blockers 65 Blood Pressure Lowering 65 Malignancies 65 mRCC 65 Cinacalcet 65 Risk Stratification 65 Acute Attacks 65 ribavirin USP 65 Erectile Dysfunction Drug 65 Antidepressant Drug 65 Pharmacokinetic 65 deep venous thromboses 65 Major Depressive Disorder MDD 65 R# #mg BID 65 Strongly Linked 65 Prostate Cancer Vaccine 65 hypertrichosis occurred 65 Enzyme Replacement Therapy 65 Chronic Inflammatory 65 Multicenter Randomized 65 Severe Acne 65 Therapeutic Efficacy 65 Atypical Antipsychotics 65 Romidepsin 65 Philadelphia Chromosome Positive 65 MULTAQ 65 INSPIRE Trial Phase III 65 oral antidiabetic medication 65 Microalbuminuria 65 Peginterferon alfa 2b 65 Uterine Cancer 65 Hematological Cancers 65 Successfully Completes Phase 65 RoACTEMRA 65 Mitral Regurgitation 65 Respiratory Syncytial Virus 65 reduce serum phosphate 65 Stable Coronary Artery 65 Telbivudine 65 Demonstrates Superior 65 Endarterectomy 65 Clinically Significant 65 CIMZIA TM certolizumab pegol 65 Oral Compound 65 orally inhaled migraine 65 Prove Effective 65 Hepatitis C Infection 65 SGOT 65 Novel Antibiotic 65 leukemia AML 65 R lenalidomide 65 Organ Rejection 65 Respiratory Virus 65 dasatinib Sprycel ® 65 Ankylosing Spondylitis 65 Anemia Drug 65 Alemtuzumab 65 Carcinoma 65 Gastrointestinal Disorders 65 Phase 1b Clinical Trial 65 Prevent Stroke 65 Novel Treatments 65 Cell Carcinoma 65 Iron Overload 65 FOLFOX6 65 HCV Genotype 65 COPAXONE R 65 Cognitive Problems 65 See WARNINGS 65 Multicenter 65 Tolvaptan 65 efavirenz EFV 65 Cardiovascular Mortality 65 Metabolic Disorder 65 Diabetic Ulcers 65 Infliximab 65 Anti Clotting Drug 65 MGd 65 bortezomib refractory 65 Roche Actemra 65 Enzastaurin 65 TRANSFORMS 65 Endocrine Therapy 65 Urinary Incontinence 65 Bronchodilator 65 Peptic Ulcer 65 Osteoporosis Treatment 65 Corticosteroid 65 Comorbid 65 FUSILEV enhances 65 Pharmacologic 65 Anti VEGF 65 Test Detects 65 Inflammatory Disease 65 ARIXTRA R 65 Nonalcoholic Steatohepatitis 65 Blood Pressure Drugs 65 biliary tract cancer 65 Begins Dosing 65 Prognostic Significance 65 Pioglitazone 65 Smoking Linked 65 Urine Test 65 Lung Cancer Drug 65 REYATAZ r arm 65 Pregnancy Linked 65 completely resected 65 Dose Escalation Study 65 Blood Flow 65 Hyperkalemia 65 Demonstrates Statistically Significant 65 Phase IIa Trial 65 recurrent glioma 65 Social Anxiety Disorder 65 Breast Cancer Treatment 65 Neovascular AMD 65 Intracerebral 65 Moxifloxacin 65 Lung Function 65 Androgen Deprivation 65 Non inferiority 65 Cocaine Addiction 65 Teriparatide 65 APTIVUS r 65 RNAi Therapeutic 65 Lubiprostone 65 Asthma Symptoms 65 Vitro Activity 65 nicardipine 65 Nocturia 65 RENAL 65 Regimens 65 Lymph Node 65 NIDDM 65 Exacerbations 65 Initiates Phase III 65 Oral Laquinimod 65 Treatment Regimen 65 Replacement Therapy 65 Bisphosphonate 65 Uterine Fibroid Embolization 65 Cervical Dystonia 65 keloid scarring 65 Abbott HUMIRA 65 purpura ITP 65 Coronary Artery Bypass Graft 65 Dementia Risk 65 retinal vein occlusion 65 Multicenter Randomized Double 65 chronic eosinophilic leukemia 65 Helps Relieve 65 grade cervical intraepithelial